Calamos Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-25,612	Closed	-$1.51M	–	1401
2022 Q3	$1.51M	Buy	+25,612	New	+$1.51M	0.01%	869
2022 Q2	–	Sell	-47,690	Closed	-$1.8M	–	1208
2022 Q1	$1.8M	Buy	+47,690	New	+$1.8M	0.01%	916